| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | NEUTRAL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.30▼ | 2.31▼ | 2.31▼ | 2.30▼ | 1.90▲ |
| MA10 | 2.30▼ | 2.30▼ | 2.30▼ | 2.10▲ | 2.14▲ |
| MA20 | 2.30▼ | 2.29▼ | 2.31▼ | 1.95▲ | 2.55▼ |
| MA50 | 2.30▼ | 2.30▼ | 2.18▲ | 2.21▲ | 2.63▼ |
| MA100 | 2.29▼ | 2.15▲ | 2.01▲ | 2.65▼ | 4.18▼ |
| MA200 | 2.30▼ | 2.00▲ | 1.99▲ | 2.66▼ | 8.19▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.001▼ | -0.011▼ | 0.076▲ | -0.060▼ |
| RSI | 39.965▼ | 47.897▼ | 51.633▲ | 57.794▲ | 47.204▼ |
| STOCH | 41.667 | 64.902 | 66.273 | 85.408▲ | 24.703 |
| WILL %R | -100.000▼ | -66.667 | -70.000 | -22.316▲ | -50.465 |
| CCI | -122.807▼ | -32.813 | -12.478 | 95.708 | -12.703 |
| CDL | $ANVS Harami Candlestick Pattern Detected | Set Alert |
|
Thursday, May 07, 2026 07:04 AM
Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/05/26 | 2.30 | 2.35 | 2.25 | 2.28 | 724,885 |
| 07/05/26 | 2.40 | 2.438 | 2.255 | 2.26 | 875,357 |
| 06/05/26 | 2.30 | 2.415 | 2.20 | 2.40 | 725,476 |
| 05/05/26 | 2.29 | 2.38 | 2.19 | 2.27 | 1,737,487 |
| 04/05/26 | 2.00 | 2.35 | 1.98 | 2.28 | 1,976,460 |
| 01/05/26 | 2.01 | 2.02 | 1.94 | 2.00 | 701,280 |
| 30/04/26 | 1.94 | 1.9999 | 1.86 | 1.97 | 1,098,120 |
| 29/04/26 | 1.90 | 1.90 | 1.79 | 1.84 | 653,023 |
| 28/04/26 | 1.89 | 2.005 | 1.85 | 1.85 | 1,330,004 |
| 27/04/26 | 1.78 | 1.935 | 1.75 | 1.89 | 1,022,138 |
|
|
||||
|
|
||||
|
|